Filtered By:
Source: Molecular Pharmaceutics
This page shows you your search results in order of relevance. This is page number 5.
Order by Relevance | Date
Total 100 results found since Jan 2013.
Antibody-Targeted Cyclodextrin-Based Nanoparticles
for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical
Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.6b01150
Source: Molecular Pharmaceutics - February 14, 2017 Category: Drugs & Pharmacology Authors: Jianfeng Guo, Eileen G. Russell, Raphael Darcy, Thomas G. Cotter, Sharon L. McKenna, Mary R. Cahill and Caitriona M. O ’Driscoll Source Type: research
Immunoprotein-Mediated siRNA Delivery
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.6b01039
Source: Molecular Pharmaceutics - February 15, 2017 Category: Drugs & Pharmacology Authors: Nicole Ba ̈umer, Wolfgang E. Berdel and Sebastian Bäumer Source Type: research
Delivering siRNA and Chemotherapeutic Molecules Across
BBB and BTB for Intracranial Glioblastoma Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.6b00819
Source: Molecular Pharmaceutics - March 2, 2017 Category: Drugs & Pharmacology Authors: Zhen-zhen Yang, Wei Gao, Yu-jie Liu, Ning Pang and Xian-rong Qi Source Type: research
In Situ Gelling Liquid Crystalline
System as Local siRNA Delivery System
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.6b01141
Source: Molecular Pharmaceutics - March 28, 2017 Category: Drugs & Pharmacology Authors: Livia N. Borgheti-Cardoso, Sander A. A. Kooijmans, Marcel H. A. M. Fens, Roy van der Meel, Fabiana T. M. C. Vicentini, Marcia C. A. Fantini, Maria Vito ́ria L. B. Bentley and Raymond M. Schiffelers Source Type: research
Promoting Vaginal Distribution of E7 and MCL-1
siRNA-Silencing Nanoparticles for Cervical Cancer Treatment
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.6b01154
Source: Molecular Pharmaceutics - April 7, 2017 Category: Drugs & Pharmacology Authors: Anna Lechanteur, Tania Furst, Brigitte Evrard, Philippe Delvenne, Ge ́raldine Piel and Pascale Hubert Source Type: research
Formulation of Nonionic Surfactant Vesicles (NISV)
Prepared by Microfluidics for Therapeutic Delivery of siRNA into Cancer
Cells
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.7b00352
Source: Molecular Pharmaceutics - June 8, 2017 Category: Drugs & Pharmacology Authors: Mohammad A. Obeid, Ashref Elburi, Louise C. Young, Alexander B. Mullen, Rothwelle J. Tate and Valerie A. Ferro Source Type: research
Natural Particulates Inspired Specific-Targeted Codelivery
of siRNA and Paclitaxel for Collaborative Antitumor Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.7b00192
Source: Molecular Pharmaceutics - August 14, 2017 Category: Drugs & Pharmacology Authors: Ruoning Wang, Ziqiang Zhao, Yue Han, Shihao Hu, Yaw Opoku-Damoah, Jianping Zhou, Lifang Yin and Yang Ding Source Type: research
Efficient siRNA Delivery by Lipid Nanoparticles Modified
with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.7b00362
Source: Molecular Pharmaceutics - August 25, 2017 Category: Drugs & Pharmacology Authors: Yu Sakurai, Wataru Mizumura, Manami Murata, Tomoya Hada, Shoshiro Yamamoto, Kenichiro Ito, Kazuhiro Iwasaki, Takayuki Katoh, Yuki Goto, Asako Takagi, Michinori Kohara, Hiroaki Suga and Hideyoshi Harashima Source Type: research
From Pulmonary Surfactant, Synthetic KL4 Peptide as
Effective siRNA Delivery Vector for Pulmonary Delivery
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.7b00725
Source: Molecular Pharmaceutics - November 17, 2017 Category: Drugs & Pharmacology Authors: Yingshan Qiu, Michael Y. T. Chow, Wanling Liang, Winnie W. Y. Chung, Judith C. W. Mak and Jenny K. W. Lam Source Type: research
pPB Peptide-Mediated siRNA-Loaded Stable Nucleic Acid
Lipid Nanoparticles on Targeting Therapy of Hepatic Fibrosis
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.7b00709
Source: Molecular Pharmaceutics - December 7, 2017 Category: Drugs & Pharmacology Authors: Zongxiang Jia, Yan Gong, Yufang Pi, Xueying Liu, Lipeng Gao, Liqing Kang, Jing Wang, Fan Yang, Jie Tang, Weiyue Lu, Qinghua Li, Wei Zhang, Zhiqiang Yan and Lei Yu Source Type: research
Nucleolin-Targeting AS1411-Aptamer-Modified Graft
Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance
Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and
Suppression of Invasion
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.7b01093
Source: Molecular Pharmaceutics - December 18, 2017 Category: Drugs & Pharmacology Authors: Shudi Yang, Zhaoxiang Ren, Mengtian Chen, Ying Wang, Bengang You, Weiliang Chen, Chenxi Qu, Yang Liu and Xuenong Zhang Source Type: research
Cationic Polymeric Nanoparticle Delivering CCR2 siRNA
to Inflammatory Monocytes for Tumor Microenvironment Modification
and Cancer Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.7b00997
Source: Molecular Pharmaceutics - January 26, 2018 Category: Drugs & Pharmacology Authors: Song Shen, Yue Zhang, Kai-Ge Chen, Ying-Li Luo and Jun Wang Source Type: research
High-Content Surface and Total Expression siRNA Kinase
Library Screen with VX-809 Treatment Reveals Kinase Targets that Enhance
F508del-CFTR Rescue
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.7b00928
Source: Molecular Pharmaceutics - February 9, 2018 Category: Drugs & Pharmacology Authors: Lydia A. Perkins, Gregory W. Fisher, Matharishwan Naganbabu, Brigitte F. Schmidt, Frederick Mun and Marcel P. Bruchez Source Type: research
Systemic Administration of siRNA with Anti-HB-EGF
Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative
Breast Cancer
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.7b01055
Source: Molecular Pharmaceutics - March 12, 2018 Category: Drugs & Pharmacology Authors: Ayaka Okamoto, Tomohiro Asai, Yusuke Hirai, Kosuke Shimizu, Hiroyuki Koide, Tetsuo Minamino and Naoto Oku Source Type: research
ASAP Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.7b01055
Source: Molecular Pharmaceutics - March 12, 2018 Category: Drugs & Pharmacology Authors: Ayaka Okamoto, Tomohiro Asai, Yusuke Hirai, Kosuke Shimizu, Hiroyuki Koide, Tetsuo Minamino, Naoto Oku Source Type: research
